Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations
2021 · Acta Neuropathologica · 54 citations
https://doi.org/10.1007/s00401-021-02291-6
W
Wies Vallentgoed
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
83
Papers
379
Citations
9
h-index
9
i10-index
Wies Vallentgoed is an academic researcher from Erasmus MC Cancer Institute. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Epigenetics and DNA Methylation & Cancer Genomics and Diagnostics. The author has an h-index of 9, co-authored 71 publications.
ORCID: 0000-0001-6373-7710Papers by this author
worksThe Epigenetic Evolution of Glioma Is Determined by the <i>IDH1</i> Mutation Status and Treatment Regimen
2023 · Cancer Research · 50 citations
https://doi.org/10.1158/0008-5472.can-23-2093
Evolutionary trajectories of IDH-mutant astrocytoma identify molecular grading markers related to cell cycling
2025 · Nature Cancer · 7 citations
https://doi.org/10.1038/s43018-025-01023-z
Gemistocytic tumor cells programmed for glial scarring characterize T cell confinement in IDH-mutant astrocytoma
2025 · Nature Communications · 3 citations
https://doi.org/10.1038/s41467-025-56441-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat